0.33Open0.33Pre Close0 Volume38 Open Interest30.00Strike Price0.00Turnover194.09%IV58.38%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type0.1201Delta0.0313Gamma58.03Leverage Ratio-0.0583Theta0.0006Rho6.97Eff Leverage0.0066Vega
Pulse Biosciences Stock Discussion
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study With Its Nano-Pfa Cardiac Surgery System
1 MINUTE AGO, 8:00 AM EST
VIA BUSINESSWIRE
No comment yet